Evaluation of lncRNA Expression Pattern and Potential Role in Heart Failure Pathology.
Xiatian ChenChengzhen ShiJinning GaoJuan Carlos Cueva JumboYin WangXin LiCheng ZhaoHua YuPeifeng LiLynn Htet Htet AungPublished in: Disease markers (2023)
During the last few decades, the morbidity and mortality of heart failure (HF) have remained on an upward trend. Despite the advances in therapeutic and diagnostic measures, there are still many aspects requiring further research. This study is aimed at finding potential long noncoding RNAs (lncRNAs) that could aid with the diagnosis and treatment of HF. We performed RNA sequencing on the peripheral blood of healthy controls as well as HF patients. The expression of lncRNAs was validated by RT-qPCR. Bioinformatic analysis was performed to investigate the possible mechanism of differentially expressed lncRNAs and mRNAs. The diagnostic value of lncRNAs was analysed by ROC analysis. Finally, a total of 207 mRNAs and 422 lncRNAs were identified. GO and KEGG pathway analyses revealed that biological pathways such as immune response, regulation of cell membrane, and transcriptional regulatory process were associated with the pathological progress of HF. The lncRNA-mRNA coexpression network was conducted, and several mRNAs were identified as key potential pathological targets, while lncRNA CHST11, MIR29B2CHG, CR381653.1, and FP236383.2 presented a potential diagnostic value for HF. These findings provide novel insights for the underlying mechanisms and possible therapeutic targets for HF.
Keyphrases
- acute heart failure
- heart failure
- genome wide analysis
- network analysis
- immune response
- poor prognosis
- peripheral blood
- long non coding rna
- genome wide identification
- transcription factor
- single cell
- end stage renal disease
- ejection fraction
- newly diagnosed
- binding protein
- gene expression
- left ventricular
- atrial fibrillation
- prognostic factors